437 results on '"Battaglin, Francesca"'
Search Results
2. q-Diffusion leverages the full dimensionality of gene coexpression in single-cell transcriptomics
3. Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer
4. Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions
5. Impact of genetic variants involved in the lipid metabolism pathway on progression free survival in patients receiving bevacizumab-based chemotherapy in metastatic colorectal cancer: a retrospective analysis of FIRE-3 and MAVERICC trials
6. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study
7. Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment
8. Upstream regulation of neurotransmitter signaling genes in metastatic colorectal cancer (mCRC) patients: Data from CALGB/SWOG 80405 trial (Alliance) and MONSTAR-SCREEN-2.
9. Molecular and immunological characterization of androgen receptor expression in different breast cancer subtypes.
10. Characterization of necroptosis activators in colorectal cancer.
11. Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets
12. Germline Polymorphisms in Genes Involved in the Antioxidant System Predict the Efficacy of Cetuximab in Metastatic Colorectal Cancer Patients Enrolled in FIRE-3 Trial
13. Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive Review.
14. Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer
15. Germline polymorphisms in genes maintaining the replication fork predict the efficacy of oxaliplatin and irinotecan in patients with metastatic colorectal cancer
16. Targeting circadian transcriptional programs in triple negative breast cancer through a cis-regulatory mechanism
17. Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancer
18. Clocking cancer: the circadian clock as a target in cancer therapy
19. HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405.
20. Molecular characteristics of BRCA1/2 and PALB2 mutations in pancreatic ductal adenocarcinoma
21. Molecular profile of BRCA-mutated biliary tract cancers
22. Identification and characterization of immunogenic neoantigens in colorectal cancer (CRC).
23. Identification and characterization of immunogenic neoantigens in biliary cancer (BC) and pancreatic cancer (PC).
24. Genomic analysis of oesophageal carcinoma (EC) to identify recurrent mutations in histone methyltransferases as a distinctive subset.
25. Molecular and immune landscape by cyclin dependent kinase (CDK) 4/6 expression and TP53 mutational status in mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) colorectal cancer (CRC).
26. Tissue factor: A link between metastatic colorectal cancer and thrombosis in patients in the CALGB (Alliance)/SWOG 80405 trial.
27. Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma.
28. Myostatin/activin pathway gene expression and single nucleotide polymorphisms (SNPs) in metastatic colorectal cancer (mCRC).
29. LMTK3 gene expression and the molecular landscape of colorectal cancer (CRC).
30. Analysis of immune-related genes (IRGs) and their potential role in sexual dimorphism in patients (pts) with metastatic colorectal cancer (mCRC).
31. Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients
32. Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patients
33. Safety and Tolerability of c-MET Inhibitors in Cancer
34. Colorectal cancer: epigenetic alterations and their clinical implications
35. Genome-wide association study (GWAS) and novel prognostic markers in metastatic colorectal cancer (mCRC).
36. How I Treat Early-Stage Colon Cancer With Adjuvant Therapy: Who and How Long?
37. Abstract 4671: MAO A, MAO B inhibitors and NMI for colon cancer therapy
38. Abstract 4234: Effects of age-diet interactions on colorectal cancer (CRC) progression in mice
39. Abstract 4124: Targeting the clock pathway to modulate immune response in MSI-high colorectal cancer (CRC): evidence from a preclinical in vivo model
40. Table S4 from RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICC
41. Figure S2 from Molecular Characterization of Appendiceal Goblet Cell Carcinoid
42. Supplementary appendix from Molecular Characterization of Appendiceal Goblet Cell Carcinoid
43. Table S2 from Molecular Characterization of Appendiceal Goblet Cell Carcinoid
44. Figure S2 from RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICC
45. Supplementary Methods from RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICC
46. Supplementary Data from Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets
47. Supplementary Figure from Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets
48. Supplementary Table from Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets
49. Data from Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets
50. Figure S5 from The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.